Back to Screener

Healthcare

Elbit Imaging Ltd.(EMITF)

Live Price

Offline

$0.05

+0.00% today

1Y Change

-97.51%

Window

Jun 26, 2025 โ†’ Jun 25, 2026

Market Cap
$80.00M
Revenue Growth
0.0%
EPS Growth
+24.0%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 26, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Elbit Imaging Ltd. (EMITF) is a Healthcare stock with a market cap of $80.00M and listed on OTC. The stock last traded around $0.05 and down 97.5% across the available one-year price window (Jun 26, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +24.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +24.0%, free cash flow -1138.7% with operating margin 0.0% and ROIC -3.6%. Stock Foundry combines EMITF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2025 was reported on May 1, 2025, but the surprise data is still limited.

The setup is mixed rather than one-directional

Revenue is 0.0% and EPS is +24.0%, while operating margin sits near 0.0%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2025
May 1, 2025
โ€”+0.0%+0.0%-8.0%
2024
Sep 30, 2024
โ€”+0.0%+0.0%-8.0%
2024
Jun 30, 2024
โ€”+0.0%+0.0%-8.0%

Benchmark Edge

EMITF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

EMITF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

EMITF Max Drawdown

-97.67%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for EMITF and SPY.

Calendar-year return history is still loading or unavailable.
Elbit Imaging Ltd. logo

Company Overview

Elbit Imaging Ltd.

Other OTC

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Leadership
Eran Mazor
IPO Date
Nov 27, 1996
Employees
3
Street Address
3 Shimson Street
Mailing
Petah Tikva, 4900102
Region
Petah Tikva, IL
Reporting Currency
USD
Investor Line
972 3 608 6000
Last Updated
Apr 28, 2026
CIK: 0001027662ISIN: IL0010811169CUSIP: M37605124
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
1.0

Growth

Revenue
0.0%
EPS
+24.0%
Free Cash Flow
-1138.7%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-8.1%
ROIC
-3.6%

Balance Sheet

Debt/Equity
0.03
Current Ratio
57.18

Earnings Reports

๐Ÿ“… Last reportedMay 1, 2025
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 1, 25
-0.17
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 24
-0.16
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 24
0.10
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 1, 24
-0.11
Est โ€”
โ€”
45.4B
Est โ€”
โ€”
โ€”
Mar 31, 24
0.10
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 23
-0.11
Est โ€”
โ€”
42.7B
Est โ€”
โ€”
โ€”
Jun 30, 23
-0.14
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 23
-0.15
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 22
0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 22
0.06
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 22
-0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 22
-0.08
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 21
-0.26
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 21
-0.25
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 21
-0.10
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 21
-0.09
Est โ€”
โ€”
โ€”
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.